RAPS pre-approved webinar on "Key Factors to develop an effective CAPA system" fromGlobalCompliancePanel

Top Quote GlobalCompliancePanel, a leading regulatory and compliance continuing education training provider, will organize a RAPS pre-approved webinar on April 9, 2013.Kim Huynh-Ba, Executive Director of Pharmalytik will be the Speaker at this session, whose topic will be"Key Factors to develop an effective CAPA system". End Quote
  • Fresno, CA (1888PressRelease) March 23, 2013 - Description:
    This webinar imparts to participants ways by which to overcome CAPA shortfalls.

    CAPA is considered the central element of Quality Management Systems. Despite this fact; and given that FDA and regulatory agencies closely inspect how pharmaceutical companies conduct their investigations, it is due toCAPA deficiencies that a significant number of FDA 483 observations and Warning Letters are cited. So, it is crucial for medical device companies to get their CAPA system right to get regulatory approval. This session will also cover regulatory requirement for a CAPA system.

    Having an effective CAPA documentation and tracking system is crucial to pharmaceutical operations because this system allows personnel to identify the root cause, corrective action taken, and verification stages. This session will discuss theimportant components with which to create an effective CAPA system and determine different levels of actions to be taken, and explains what training is needed to prevent reoccurrence.

    This webinar will cover the following areas:
    - Why an effective CAPA system is important
    - Roles and responsibilities of manufacturers
    - Identifying sources of infractions
    - Determining root causes
    - CAPA Tracking System and documentation

    When:April 9, 2013, 2013,10:00 AM PDT | 01:00 PM EDT

    By whom:
    Kim Huynh-Ba is the Executive Director of Pharmalytik, where she provides consulting and training services to pharmaceutical companies, including companies operating under FDA's Consent Decree on harmonization and optimization of analytical best practices. She has almost 25 years of experience in analytical development, project management, strategic drug development and stability sciences.

    Kim is also a short course instructor on cGMP compliance and quality topics for several global organizations and many other international training groups. She is an Adjunct Professor at Temple University-School of Pharmacy, Widener University and Illinois Institute of Technology (IIT) teaching pharmaceutical analysis and analytical chemistry graduate courses.

    Kim is a member of the Executive Committee of Governing Board of Eastern Analytical Symposium (EAS) and will be their 2013 President. She is the Chair of USP Good Documentation Practices Expert Panel (2010-15) and a member of USP Impurities of Drug Products Expert Panel (2012-15). Kim is a recipient of the 2008 Service Award of Analysis and Pharmaceutical Quality Section and 2008 Recognition Award of Regulatory Section of AAPS. She also received the 2001 DuPont Pharmaceutical Company Asian American Leadership Award.

    For whom:
    The webinar will benefit
    - Laboratory Analysts
    - Quality Assurance scientists
    - QA/QC analysts
    - QA/QC managers
    - Auditors
    - Inspectors
    - Pharmaceutical development and manufacturing personnel
    - Manufacturers of raw materials and excipients
    - Contract laboratory Organization personnel.

    Duration: 60 minutes

    To enroll for this webinar, contact
    webinars ( @ ) globalcompliancepanel dot com
    Phone: 800-447-9407

  • FB Icon Twitter Icon In-Icon
Contact Information